enGene Logo in transparent PNG format

enGene Logo in large size

enGene Logo icon format

enGene Logo in large size for dark backgrounds

enGene Logo icon format for dark backgrounds

About enGene

enGene Holdings Inc., through its subsidiary enGene, Inc., operates as a clinical-stage biotechnology company that develops genetic medicines through the delivery of therapeutics to mucosal tissues and other organs. Its lead product candidate is EG-70 (detalimogene voraplasmid), which is a non-viral immunotherapy to treat non-muscle invasive bladder cancer patients with carcinoma-in-situ (Cis), who are unresponsive to treatment with Bacillus Calmette-GuΓ©rin. The company was founded in 2023 and is based in Saint-Laurent, Canada.

Page last updated on:

calendar iconMarch 10th, 2024